/nginx/o/2019/10/28/12695038t1h523e.jpg?fit=%2C&ssl=1 "Oxford University and AstraZeneca resume clinical trials of Covid-19 vaccine – Abroad – News")
The trials resumed after obtaining the consent of the British Medicines Agency, according to a statement issued by the University of Oxford on Saturday.
–
The resumption of trials is “good news for everyone,” British Health Minister Mats Hankok has posted on Twitter.
–
For the same reasons, testing of the vaccine was suspended for several days in July.
–
The vaccine has so far been injected into 18,000 volunteers worldwide, including the UK, US, Brazil and South Africa, according to Oxford University.
–
AstraZeneca is one of nine companies whose potential Covid-19 vaccines are in the Phase 3 trials. It is one of the vaccines reserved for the European Commission.
–
According to AstraZeneca, the vaccine could be ready later this year or early next year.
–
